Atlas Trials

24-Week Recurrence Rate of Gout Following Firsekibart Treatment

Clinical trial NCT07625514 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07625514
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Gout Flare
Start date
2026-05-07
Primary completion
2029-08-28
Enrollment
264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.